Cigna Investments’s Exelon EXC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $456K | Hold |
9,775
| – | – | 0.06% | 278 |
|
|
2026
Q1 | $479K | Hold |
9,775
| – | – | 0.07% | 246 |
|
|
2025
Q4 | $426K | Sell |
9,775
-150
| -2% | -$6.85K | 0.06% | 263 |
|
|
2025
Q3 | $447K | Hold |
9,925
| – | – | 0.06% | 261 |
|
|
2025
Q2 | $431K | Sell |
9,925
-206
| -2% | -$9.17K | 0.07% | 253 |
|
|
2025
Q1 | $467K | Sell |
10,131
-125
| -1% | -$5.22K | 0.09% | 231 |
|
|
2024
Q4 | $386K | Hold |
10,256
| – | – | 0.07% | 281 |
|
|
2024
Q3 | $416K | Sell |
10,256
-188
| -2% | -$7.07K | 0.07% | 266 |
|
|
2024
Q2 | $362K | Sell |
10,444
-128
| -1% | -$4.72K | 0.07% | 293 |
|
|
2024
Q1 | $397K | Hold |
10,572
| – | – | 0.07% | 277 |
|
|
2023
Q4 | $379K | Hold |
10,572
| – | – | 0.08% | 274 |
|
|
2023
Q3 | $400K | Sell |
10,572
-1,373
| -11% | -$55.9K | 0.09% | 229 |
|
|
2023
Q2 | $487K | Hold |
11,945
| – | – | 0.09% | 224 |
|
|
2023
Q1 | $501K | Sell |
11,945
-243
| -2% | -$10.1K | 0.1% | 208 |
|
|
2022
Q4 | $526K | Hold |
12,188
| – | – | 0.11% | 196 |
|
|
2022
Q3 | $456K | Sell |
12,188
-410
| -3% | -$18.1K | 0.1% | 202 |
|
|
2022
Q2 | $571K | Sell |
12,598
-4,532
| -26% | -$213K | 0.11% | 180 |
|
|
2022
Q1 | $816K | Sell |
17,130
-13,710
| -44% | -$581K | 0.1% | 193 |
|
|
2021
Q4 | $1.27M | Sell |
30,840
-11,113
| -26% | -$419K | 0.1% | 164 |
|
|
2021
Q3 | $1.45M | Sell |
41,953
-561
| -1% | -$19.2K | 0.11% | 164 |
|
|
2021
Q2 | $1.34M | Sell |
42,514
-6,608
| -13% | -$213K | 0.1% | 179 |
|
|
2021
Q1 | $1.53M | Buy |
49,122
+1,647
| +3% | +$49.5K | 0.11% | 166 |
|
|
2020
Q4 | $1.43M | Buy |
47,475
+3,629
| +8% | +$107K | 0.11% | 162 |
|
|
2020
Q3 | $1.12M | Sell |
43,846
-9
| -0% | -$239 | 0.11% | 169 |
|
|
2020
Q2 | $1.14M | Buy |
43,855
+5,667
| +15% | +$150K | 0.11% | 177 |
|
|
2020
Q1 | $1M | Buy |
38,188
+2,314
| +6% | +$72.8K | 0.13% | 181 |
|
|
2019
Q4 | $1.22M | Sell |
35,874
-4,023
| -10% | -$130K | 0.13% | 208 |
|
|
2019
Q3 | $1.29M | Buy |
39,897
+2,067
| +5% | +$69.4K | 0.13% | 196 |
|
|
2019
Q2 | $1.22M | Sell |
37,830
-1,192
| -3% | -$42.1K | 0.13% | 205 |
|
|
2019
Q1 | $1.4M | Sell |
39,022
-317
| -0.8% | -$10.8K | 0.15% | 152 |
|
|
2018
Q4 | $1.26M | Buy |
39,339
+354
| +0.9% | +$11.3K | 0.11% | 138 |
|
|
2018
Q3 | $1.22M | Sell |
38,985
-3,905
| -9% | -$120K | 0.1% | 157 |
|
|
2018
Q2 | $1.3M | Sell |
42,890
-6,029
| -12% | -$173K | 0.09% | 192 |
|
|
2018
Q1 | $1.36M | Sell |
48,919
-420
| -0.9% | -$11.3K | 0.09% | 187 |
|
|
2017
Q4 | $1.39M | Sell |
49,339
-1,757
| -3% | -$50.5K | 0.09% | 168 |
|
|
2017
Q3 | $1.37M | Buy |
51,096
+1,103
| +2% | +$29.5K | 0.09% | 172 |
|
|
2017
Q2 | $1.29M | Sell |
49,993
-3,147
| -6% | -$80.1K | 0.09% | 190 |
|
|
2017
Q1 | $1.36M | Buy |
53,140
+6,045
| +13% | +$154K | 0.09% | 190 |
|
|
2016
Q4 | $1.19M | Buy |
+47,095
| New | +$1.12M | 0.13% | 196 |
|
Other funds holding EXC
Cigna Investments's EXC Position: Q2 2026 in Review
Cigna Investments held its Exelon (EXC) position steady in Q2 2026 at 9,775 shares worth $456K. The position accounts for 0.06% of the portfolio, ranked #278.
Cigna Investments first reported a position in EXC in Q4 2016 and has held it in 39 quarters since. The position peaked at $1.53M in Q1 2021. 1,286 funds tracked by Wall St. Rank hold EXC as of Q2 2026.
- Cigna Investments held 9,775 shares of Exelon worth $456K as of Q2 2026.
- Cigna Investments left its Exelon share count unchanged in Q2 2026.
- Exelon made up 0.06% of Cigna Investments's portfolio in Q2 2026, its #278 holding.
- Cigna Investments first reported a position in Exelon in Q4 2016 and has held it in 39 quarters since.
- Cigna Investments's Exelon position peaked at $1.53M in Q1 2021.
- 1,286 funds tracked by Wall St. Rank held Exelon as of Q2 2026.
Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.